Search

Author/Creator Fischer, Bruce

1. 393 First-in-human phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: initial phase 1 results. (9th November 2020)

Authors:
Friedman, Claire; Ascierto, Paolo; Davar, Diwakar; O'Hara, Mark; Shapira-Frommer, Ronnie; Dallos, Matthew; Khemka, Vivek; James, Lee; Fischer, Bruce; Demes, Shilpa; Li, Li; Kozicki, Martin; Ravindran, Palanikumar; Xu, Ke; Kollia, Georgia; Shoukry, Jacqueline; Yunan, Mona; Massey, Ashish; Gutierre...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A418
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 393 First-in-human phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: initial phase 1 results. (9th November 2020)

Authors:
Friedman, Claire; Ascierto, Paolo; Davar, Diwakar; O'Hara, Mark; Shapira-Frommer, Ronnie; Dallos, Matthew; Khemka, Vivek; James, Lee; Fischer, Bruce; Demes, Shilpa; Li, Li; Kozicki, Martin; Ravindran, Palanikumar; Xu, Ke; Kollia, Georgia; Shoukry, Jacqueline; Yunan, Mona; Massey, Ashish; Gutierre...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search